cln-081,amivantamab-vmjw
otsuka,genmab,cullinan oncology,janssen
['sclc', 'nsclc', 'cln-081 ', 'rybrevant', 'otsuka']
cln-081 in exon 20 ins nsclc via helen yu #asco22 cutoff in may, which was when $cgem sold this off to otsuka. 2/3 post mobo/rybrevant pts had responses. 
Journalist at Evaluate Vantage. Proudly blocked by @JohnCendpts. Interested in: oncology, immunology. Not interested in: what stock you bought today.